Fanying Meng Selected Research

stirocainide

5/2008

A novel class of tubulin inhibitors that exhibit potent antiproliferation and in vitro vessel-disrupting activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fanying Meng Research Topics

Disease

10	Neoplasms (Cancer) 01/2021 - 03/2007
7	Hypoxia (Hypoxemia) 01/2019 - 04/2007
2	Adenocarcinoma 01/2015 - 05/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2015 - 05/2008
2	Neuralgia (Stump Neuralgia) 07/2013 - 01/2012
1	Sepsis (Septicemia) 08/2022
1	Bone Resorption 05/2022
1	Bone Diseases (Bone Disease) 01/2022
1	Photosensitivity Disorders (Photodermatitis) 02/2021
1	Insulin Resistance 12/2020
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019
1	Neuroblastoma 08/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2016
1	Critical Illness (Critically Ill) 04/2016
1	Hypophosphatemia 04/2016
1	Shoulder Pain 01/2015
1	Stroke (Strokes) 01/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2015
1	Pain (Aches) 07/2013
1	Multiple Sclerosis 03/2011
1	Rheumatoid Arthritis 03/2011
1	Hematologic Neoplasms (Hematological Malignancy) 05/2008
1	Carcinogenesis 04/2007

Drug/Important Bio-Agent (IBA)

8	ProdrugsIBA 01/2021 - 03/2012
6	TH 302IBA 01/2019 - 03/2012
5	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 03/2012
4	isophosphamide mustard (IPAM)IBA 05/2015 - 03/2012
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
3	Pharmaceutical PreparationsIBA 08/2018 - 04/2007
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2012
2	Oxygen (Dioxygen)IBA 01/2019 - 04/2007
2	azomycinIBA 01/2015 - 03/2012
2	Proteins (Proteins, Gene)FDA Link 07/2013 - 04/2007
1	TitaniumIBA 05/2022
1	MetalsIBA 02/2021
1	SugarsIBA 12/2020
1	Polysaccharides (Glycans)IBA 12/2020
1	Small Interfering RNA (siRNA)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	nelarabine (506U78)FDA Link 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	Sunitinib (Sutent)FDA Link 08/2018
1	NitroimidazolesIBA 05/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	temsirolimus FDA Link 01/2015
1	Gemcitabine FDA Link 01/2015
1	MTOR InhibitorsIBA 01/2015
1	Everolimus FDA Link 01/2015
1	130-nm albumin-bound paclitaxelIBA 01/2015
1	NucleotidesIBA 03/2012
1	AcetylcholinesteraseIBA 01/2012
1	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 01/2012
1	Muscarinic M1 ReceptorIBA 01/2012
1	Cholinergic Agents (Cholinergics)IBA 01/2012
1	compound 17IBA 03/2011
1	multidrug resistance-associated protein 1IBA 05/2008
1	Antineoplastic Agents (Antineoplastics)IBA 05/2008
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 05/2008
1	stirocainideIBA 05/2008
1	Tubulin ModulatorsIBA 05/2008
1	Topotecan (Hycamtin)FDA LinkGeneric 04/2007
1	topovaleIBA 04/2007
1	Transcription Factors (Transcription Factor)IBA 04/2007
1	NocodazoleIBA 04/2007
1	Topoisomerase I InhibitorsIBA 04/2007
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 04/2007
1	Cytotoxins (Cytolysins)IBA 03/2007
1	IndazolesIBA 03/2007
1	AcetyleneIBA 03/2007

Therapy/Procedure

7	Therapeutics 08/2022 - 04/2007
2	Radiotherapy 01/2015 - 01/2015
2	Electroacupuncture 07/2013 - 01/2012
1	Drug Therapy (Chemotherapy) 01/2021
1	Castration 01/2021
1	Artificial Respiration (Mechanical Ventilation) 04/2016
1	Percutaneous Collagen Induction 01/2015
1	Acupuncture Therapy 07/2013